Roche’s Risdiplam meets primary endpoint in pivotal FIREFISH trial in infants with type 1 spinal muscular atrophy

Liz Kane
Impactful Strategy

David Linetsky
Patient Activation

Matthew Durham
Omnidynamic Marketing

Frank Burrell
Scientific Storytelling

Frank X. Powers
Healthcare Challenger Brands

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Thomas Shea
Programmatic Marketing

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

Matt Turner
Patient Affordability

Daniel Sontupe
Market Access

Brenda Snow
Authentic Patient Voice

Anil Bhaskar
Unified Customer Experience

Suma Ramadas, PhD
Medical Affairs

Mike Viscel
Increasing Engagement

Laura Blair
Medication Adherence